Cantor Fitzgerald Forecasts Krystal Biotech FY2025 Earnings
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Krystal Biotech in a research report issued to clients and investors on Thursday, February 20th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will earn $6.22 per share for the year. Cantor Fitzgerald […]
